The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FHINCH study: Fertility and sexual health effects of cancer therapy in young women with lung cancer and melanoma.
 
Narjust Florez
Employment - Dana Farber Cancer Hospital
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech; Janssen; Jazz Pharmaceuticals; Merck; Mirati Therapeutics; NeoGenomics Laboratories; Novocure; Nuvation Bio; Pfizer; Regeneron
Research Funding - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech
Other Relationship - Clinical Care Options; CME Outfitters; CME Outfitters; IDEOlogy Health; Medscape; PER; Precisca
 
Lauren Kiel
No Relationships to Disclose
 
Rebekah Kaufman
Employment - Dana-Farber Cancer Institute
Travel, Accommodations, Expenses - Dana-Farber Cancer Institute
 
Courtney Mantz
Employment - Boston Children's Hospital; Boston Children's Hospital (I); Dana Farber Cancer Hospital
Research Funding - Dana Farber Cancer Hospital
Travel, Accommodations, Expenses - Dana Farber Cancer Hospital
 
Angela Morabito
Employment - Dana-Farber Cancer Institute
Travel, Accommodations, Expenses - Dana-Farber Cancer Institute
 
Kelly Meza
No Relationships to Disclose
 
Matteo Lambertini
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Gilead Sciences; Lilly; Menarini; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Ipsen; Knight Therapeutics; Libbs; Lilly; Menarini; Novartis; Pfizer; Roche; Sandoz; Takeda
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH; Gilead Sciences; Roche
 
Mary Frates
No Relationships to Disclose
 
Ruth Lederman
No Relationships to Disclose
 
Sharon Bober
No Relationships to Disclose
 
Elizabeth Buchbinder
Employment - Alexion Pharmaceuticals (I); Takeda (I)
Consulting or Advisory Role - Instil Bio; Iovance Biotherapeutics; Merck; Nektar; Novartis; Pfizer; Sanofi; Werewolf Pharma; Xilio Therapeutics
Research Funding - Bristol-Myers Squibb; Checkmate Pharmaceuticals; Genentech/Roche; Lilly; Novartis
 
Elizabeth Ginsburg
No Relationships to Disclose
 
Andrea Enzinger
Consulting or Advisory Role - Astellas Pharma (I); AstraZeneca (I); Daiichi Sankyo (I); Five Prime Therapeutics (I); Istari (I); Lilly (I); loxo (I); Merck (I); Novartis (I); Ono Pharmaceutical (I); Taiho Pharmaceutical (I); Takeda (I); Xencor (I); Zymeworks (I); Zymeworks (I)
Research Funding - Medtronic
 
Ann Partridge
Patents, Royalties, Other Intellectual Property - Wolters Kluwer- royalties for authorship of UpToDate